Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent C. Diff”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Early research (Phase 1)UnknownNCT02134392
What this trial is testing

Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection

Who this might be right for
Clostridium Difficile
Jonathan Gisser 15
Testing effectiveness (Phase 2)Study completedNCT03497806
What this trial is testing

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more
Finch Research and Development LLC. 132
Testing effectiveness (Phase 2)Study completedNCT02589847
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Rebiotix Inc. 272
Not applicableLooking for participantsNCT01905709
What this trial is testing

Fecal Microbiota Transplantation for C Diff Infection

Who this might be right for
Clostridium Difficile Infection
Englewood Hospital and Medical Center 100
Not applicableUnknownNCT01973465
What this trial is testing

Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis

Who this might be right for
Clostridium Difficile
OSF Healthcare System 10
Not applicableLooking for participantsNCT07250724
What this trial is testing

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Who this might be right for
Clostridioides Difficile Infection Recurrence
Bactolife A/S 60
Large-scale testing (Phase 3)Looking for participantsNCT06237452
What this trial is testing

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium DifficileClostridium Difficile InfectionsClostridium Difficile Infection Recurrence+7 more
Vedanta Biosciences, Inc. 852
Testing effectiveness (Phase 2)Study completedNCT03110133
What this trial is testing

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

Who this might be right for
Clostridium Difficile Infection Recurrence
Finch Research and Development LLC. 206
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Post-approval studies (Phase 4)Ended earlyNCT03200093
What this trial is testing

Oral Vancomycin for Preventing Clostridium Difficile Recurrence

Who this might be right for
Clostridium Difficile Infection
Rochester General Hospital 65
Testing effectiveness (Phase 2)Study completedNCT03462459
What this trial is testing

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Recurrent Clostridium Difficile InfectionClostridium Difficile InfectionCDI+3 more
University of Wisconsin, Madison 79
Large-scale testing (Phase 3)Study completedNCT03931941
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)

Who this might be right for
Clostridium Difficile InfectionInfectionCommunicable Diseases
Rebiotix Inc. 793
Testing effectiveness (Phase 2)Looking for participantsNCT07285213
What this trial is testing

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 230
Post-approval studies (Phase 4)Ended earlyNCT04626947
What this trial is testing

Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease+1 more
David Binion, MD 19
Large-scale testing (Phase 3)Study completedNCT02254811
What this trial is testing

FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
University of Alberta 116
Testing effectiveness (Phase 2)Study completedNCT03353506
What this trial is testing

Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection

Who this might be right for
EnterocolitisRecurrent Clostridium Difficile Infection
Dina Kao 11
Testing effectiveness (Phase 2)Study completedNCT01925417
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Who this might be right for
Recurrent Clostridium Difficile Infection
Rebiotix Inc. 34
Testing effectiveness (Phase 2)Ended earlyNCT02255305
What this trial is testing

FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI

Who this might be right for
Clostridium Difficile Infection
Endeavor Health 6
Testing effectiveness (Phase 2)Study completedNCT03788434
What this trial is testing

Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection RecurrenceClostridium Difficile InfectionClostridium Difficile+4 more
Vedanta Biosciences, Inc. 79
Early research (Phase 1)Study completedNCT02830542
What this trial is testing

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Who this might be right for
Clostridium Difficile Infection
Seres Therapeutics, Inc. 96
Load More Results